CASELLI, Emilia
CASELLI, Emilia
Dipartimento di Scienze della Vita
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols
2003 Caselli, Emilia; Danieli, Chiara; Morandi, Stefania; B., Bonfiglio; Forni, Arrigo; Prati, Fabio
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase
2020 Caselli, E.; Fini, F.; Introvigne, M. L.; Stucchi, M.; Taracila, M. A.; Fish, E. R.; Smolen, K. A.; Rather, P. N.; Powers, R. A.; Wallar, B. J.; Bonomo, R. A.; Prati, F.
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
2002 Susan L., Mcgovern; Caselli, Emilia; Nikolaus, Grigorieff; Brian K., Shoichet
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii
2021 Hujer, A. M.; Hujer, K. M.; Leonard, D. A.; Powers, R. A.; Wallar, B. J.; Mack, A. R.; Taracila, M. A.; Rather, P. N.; Higgins, P. G.; Prati, F.; Caselli, E.; Marshall, S. H.; Clarke, T.; Greco, C.; Venepally, P.; Brinkac, L.; Kreiswirth, B. N.; Fouts, D. E.; Bonomo, R. A.
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor.
2016 Bonomo, Robert; Prati, Fabio; Caselli, Emilia; Romagnoli, Chiara
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes
L. C., Blaszczak; Caselli, Emilia; Prati, Fabio; B. K., Shoichet
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli
2003 B., Bonfiglio; Caselli, Emilia; Forni, Arrigo; Danieli, Chiara; Prati, Fabio
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol
2004 Tosi, Giovanni; F., Zironi; Caselli, Emilia; Forni, Arrigo; Prati, Fabio
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii
2014 R. A., Powers; H. C., Swanson; M. A., Taracila; N. W., Florek; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; R. A., Bonomo; B. J., Wallar
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases
Prati, Fabio; Caselli, Emilia
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design
2016 Rojas, Laura J.; Taracila, Magdalena A.; Papp Wallace, Krisztina M.; Bethel, Christopher R.; Caselli, Emilia; Romagnoli, Chiara; Winkler, Marisa L.; Spellberg, Brad; Prati, Fabio; Bonomo, Robert A.
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses
2023 Alsenani, Tahani A; Rodríguez, María Margarita; Ghiglione, Barbara; Taracila, Magdalena A; Mojica, Maria F; Rojas, Laura J; Hujer, Andrea M; Gutkind, Gabriel; Bethel, Christopher R; Rather, Philip N; Introvigne, Maria Luisa; Prati, Fabio; Caselli, Emilia; Power, Pablo; van den Akker, Focco; Bonomo, Robert A
Chemo-enzymatic synthesis of levodropropizine
2003 Caselli, Emilia; Tosi, Giovanni; Forni, Arrigo; Bucciarelli, Maria; Prati, Fabio
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors
2015 Caselli, Emilia; Romagnoli, Chiara; Vahabi, Roza; Taracila, Magdalena A; Bonomo, Robert A; Prati, Fabio
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030
2016 Nguyen, Nhu Q.; Krishnan, Nikhil P.; Rojas, Laura J.; Prati, Fabio; Caselli, Emilia; Romagnoli, Chiara; Bonomo, Robert A.; Van Den Akker, Focco
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa
2018 Barnes, Melissa D.; Taracila, Magdalena A.; Rutter, Joseph D.; Bethel, Christopher R.; Galdadas, Ioannis; Hujer, Andrea M.; Caselli, Emilia; Prati, Fabio; Dekker, John P.; Papp-Wallace, Krisztina M.; Haider, Shozeb; Bonomo, Robert A.
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
2023 Lu, Peggy; Alletto, Francesco; Lee, Bosul; Burk, Elizabeth; Martinez, Jasmine; Prati, Fabio; Caselli, Emilia; Spellberg, Brad; Luna, Brian
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase
2013 Marisa L., Winkler; Elizabeth A., Rodkey; Magdalena A., Taracila; Sarah M., Drawz; Christopher R., Bethel; Krisztina M., Papp Wallace; Kerri M., Smith; Yan, Xu; Jeffrey R., Dwulit Smith; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; Focco van den, Akker; Robert A., Bonomo
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors
2010 Oliv, Eidam; Romagnoli, Chiara; Caselli, Emilia; Joel, Karpiak; Kerim, Babaoglu; Denise Teotico, Pohlhaus; Richard, Bonnet; Brian K., Shoichet; Prati, Fabio
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method
2005 Morandi, Stefania; Caselli, Emilia; Forni, Arrigo; Bucciarelli, Maria; Torre, Giovanni; Prati, Fabio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols | 1-gen-2003 | Caselli, Emilia; Danieli, Chiara; Morandi, Stefania; B., Bonfiglio; Forni, Arrigo; Prati, Fabio | |
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase | 1-gen-2020 | Caselli, E.; Fini, F.; Introvigne, M. L.; Stucchi, M.; Taracila, M. A.; Fish, E. R.; Smolen, K. A.; Rather, P. N.; Powers, R. A.; Wallar, B. J.; Bonomo, R. A.; Prati, F. | |
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening | 1-gen-2002 | Susan L., Mcgovern; Caselli, Emilia; Nikolaus, Grigorieff; Brian K., Shoichet | |
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii | 1-gen-2021 | Hujer, A. M.; Hujer, K. M.; Leonard, D. A.; Powers, R. A.; Wallar, B. J.; Mack, A. R.; Taracila, M. A.; Rather, P. N.; Higgins, P. G.; Prati, F.; Caselli, E.; Marshall, S. H.; Clarke, T.; Greco, C.; Venepally, P.; Brinkac, L.; Kreiswirth, B. N.; Fouts, D. E.; Bonomo, R. A. | |
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. | 6-set-2016 | Bonomo, Robert; Prati, Fabio; Caselli, Emilia; Romagnoli, Chiara | |
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes | - | L. C., Blaszczak; Caselli, Emilia; Prati, Fabio; B. K., Shoichet | |
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli | 1-gen-2003 | B., Bonfiglio; Caselli, Emilia; Forni, Arrigo; Danieli, Chiara; Prati, Fabio | |
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol | 1-gen-2004 | Tosi, Giovanni; F., Zironi; Caselli, Emilia; Forni, Arrigo; Prati, Fabio | |
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii | 1-gen-2014 | R. A., Powers; H. C., Swanson; M. A., Taracila; N. W., Florek; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; R. A., Bonomo; B. J., Wallar | |
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases | - | Prati, Fabio; Caselli, Emilia | |
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design | 1-gen-2016 | Rojas, Laura J.; Taracila, Magdalena A.; Papp Wallace, Krisztina M.; Bethel, Christopher R.; Caselli, Emilia; Romagnoli, Chiara; Winkler, Marisa L.; Spellberg, Brad; Prati, Fabio; Bonomo, Robert A. | |
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses | 1-gen-2023 | Alsenani, Tahani A; Rodríguez, María Margarita; Ghiglione, Barbara; Taracila, Magdalena A; Mojica, Maria F; Rojas, Laura J; Hujer, Andrea M; Gutkind, Gabriel; Bethel, Christopher R; Rather, Philip N; Introvigne, Maria Luisa; Prati, Fabio; Caselli, Emilia; Power, Pablo; van den Akker, Focco; Bonomo, Robert A | |
Chemo-enzymatic synthesis of levodropropizine | 1-gen-2003 | Caselli, Emilia; Tosi, Giovanni; Forni, Arrigo; Bucciarelli, Maria; Prati, Fabio | |
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors | 1-gen-2015 | Caselli, Emilia; Romagnoli, Chiara; Vahabi, Roza; Taracila, Magdalena A; Bonomo, Robert A; Prati, Fabio | |
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 | 1-gen-2016 | Nguyen, Nhu Q.; Krishnan, Nikhil P.; Rojas, Laura J.; Prati, Fabio; Caselli, Emilia; Romagnoli, Chiara; Bonomo, Robert A.; Van Den Akker, Focco | |
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa | 1-gen-2018 | Barnes, Melissa D.; Taracila, Magdalena A.; Rutter, Joseph D.; Bethel, Christopher R.; Galdadas, Ioannis; Hujer, Andrea M.; Caselli, Emilia; Prati, Fabio; Dekker, John P.; Papp-Wallace, Krisztina M.; Haider, Shozeb; Bonomo, Robert A. | |
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates | 1-gen-2023 | Lu, Peggy; Alletto, Francesco; Lee, Bosul; Burk, Elizabeth; Martinez, Jasmine; Prati, Fabio; Caselli, Emilia; Spellberg, Brad; Luna, Brian | |
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase | 1-gen-2013 | Marisa L., Winkler; Elizabeth A., Rodkey; Magdalena A., Taracila; Sarah M., Drawz; Christopher R., Bethel; Krisztina M., Papp Wallace; Kerri M., Smith; Yan, Xu; Jeffrey R., Dwulit Smith; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; Focco van den, Akker; Robert A., Bonomo | |
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors | 1-gen-2010 | Oliv, Eidam; Romagnoli, Chiara; Caselli, Emilia; Joel, Karpiak; Kerim, Babaoglu; Denise Teotico, Pohlhaus; Richard, Bonnet; Brian K., Shoichet; Prati, Fabio | |
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method | 1-gen-2005 | Morandi, Stefania; Caselli, Emilia; Forni, Arrigo; Bucciarelli, Maria; Torre, Giovanni; Prati, Fabio |